SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-004229
Filing Date
2018-04-10
Accepted
2018-04-10 14:23:06
Documents
2
Period of Report
2018-04-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k040918b_immudyneinc.htm 8-K 15094
2 IMMUDYNE, INC. BY-LAWS, DATED APRIL 9, 2018 f8k040918bex3-1_immudyne.htm EX-3.1 66153
  Complete submission text file 0001213900-18-004229.txt   82443
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18747739
SIC: 2833 Medicinal Chemicals & Botanical Products